Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Female sexual dysfunction.

J R Berman1, I Goldstein

  • 1Center for Female Sexual Medicine, Department of Urology, University of California Los Angeles Medical Center, Los Angeles, California, USA.

The Urologic Clinics of North America
|June 14, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ovarian stimulation for fertility treatments and risk of breast cancer: a matched cohort study.

Human reproduction (Oxford, England)·2021
Same author

Feasibility of Patient-Reported Outcomes Measurement Information System (PROMIS®) computerized adaptive tests in systemic lupus erythematosus outpatients.

Lupus·2018
Same author

Inhibition of P210BCR/ABL Expression in K562 Cells by Electroporation with an Antisense Oligonucleotide.

Leukemia & lymphoma·2016
Same author

Novel p53 target genes secreted by the liver are involved in non-cell-autonomous regulation.

Cell death and differentiation·2015
Same author

The onset of p53 loss of heterozygosity is differentially induced in various stem cell types and may involve the loss of either allele.

Cell death and differentiation·2014
Same author

[Problem of early diagnosis in rheumatic diseases; changes in the leukogram and V.S.H. after intradermal injection of streptococcic antigen].

Probleme de reumatologie·2014
Same journal

An Unprecedented Era of Innovation in Non-Muscle-Invasive Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Hubert Humphrey's Bladder Cancer: If He Could Have Time Traveled, Would that Have Changed the Outcome?

The Urologic clinics of North America·2026
Same journal

Key Clinical Trials Shaping the Future of Superficial High-Risk Bladder Cancer Management.

The Urologic clinics of North America·2026
Same journal

Future Directions: Artificial Intelligence and Digital Tools in Bladder Cancer Care.

The Urologic clinics of North America·2026
Same journal

Economic Considerations in the Management of Superficial Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Patient-Centered Approaches to Non-Muscle-Invasive Bladder Cancer Care.

The Urologic clinics of North America·2026
See all related articles

Female sexual dysfunction requires a distinct approach compared to male sexual dysfunction. A comprehensive medical, psychosocial, and partner-inclusive evaluation is crucial before treatment.

Area of Science:

  • Reproductive Medicine
  • Psychiatry
  • Sexual Health

Background:

  • Female sexual dysfunction (FSD) is a complex condition with unique characteristics distinct from male sexual dysfunction.
  • Understanding the nuances of female sexuality within its psychosocial context is essential for effective clinical management.

Purpose of the Study:

  • To emphasize the necessity of a distinct clinical approach for female sexual dysfunction.
  • To highlight the importance of a comprehensive evaluation integrating medical, psychosocial, and partner-inclusive aspects.

Main Methods:

  • Review of existing literature on female sexual dysfunction and its comparison with male sexual dysfunction.
  • Analysis of the multifaceted nature of FSD, considering both physiological and contextual factors.

Related Experiment Videos

  • Emphasis on the collaborative role of therapists and physicians in the evaluation and treatment process.

    • Main Results:

    • Female sexual dysfunction is fundamentally different from male sexual dysfunction, necessitating tailored clinical strategies.
    • A complete medical and psychosocial evaluation, including the partner, is integral to understanding and addressing FSD.
    • The contextual factors influencing a woman's sexual experience are as critical as physiological outcomes.

    Conclusions:

    • The management of female sexual dysfunction demands a specialized, collaborative approach.
    • Clinicians must recognize the unique physiological and psychosocial dimensions of FSD.
    • Prioritizing comprehensive patient and partner evaluation is paramount before initiating medical therapy for FSD.